Ad hoc News

Zur Rose Group AG publishes invitation to the Annual General Meeting of 28 April 2022
Ad hoc announcement pursuant to Art. 53 LR

Zur Rose Group: Excellent starting position for e-prescriptions set up and ecosystem strategy successfully continued
Ad hoc announcement pursuant to Art. 53 LR

Zur Rose Group successfully completed capital increase from authorised capital and sets placement price at CHF 290 per new share
Ad hoc announcement pursuant to Art. 53 LR

Zur Rose Group decides on capital increase from authorised capital and starts accelerated bookbuilding to make full use of increasing market opportunities
Ad hoc announcement pursuant to Art. 53 LR

Zur Rose Group: Board of Directors nominates Walter Oberhänsli as Chairman and appoints Walter Hess as new CEO
Ad hoc announcement pursuant to Art. 53 LR

Zur Rose Group continues to grow strongly
Ad hoc announcement pursuant to Art. 53 LR

Zur Rose Group accelerates growth in second quarter with revenue up 26 per cent
Ad hoc announcement pursuant to Art. 53 LR

At the moment no ad-hoc announcements are available.

Archive

Button open menu

Button close menu